Tuesday, August 30, 2022 Daily Archives

Beyond the peak: Catalent prepped for two-third cut in COVID revenues

by

Increased cell and gene therapy, drug product, and drug substance demand will offset the considerable decline in COVID-19 revenues in FY 2023, says CDMO Catalent. The contract development and manufacturing organization (CDMO) reported its results this week, with its Biologics division – which represents over 50% of its business – pulling in $667 million in Q4 (up 14% year-on-year) and $2.55 billion for the full fiscal year 2022 (up 34%). Catalent’s Biologics segment includes the development and manufacturing for biologic…

August 30, 2022

ChargePoint ups SU tech with PuroVaso buy

by

ChargePoint Technology has acquired PuroVaso, a development and production firm of single-use containers, equipment, and accessories for the biopharma industry. The deal, of which financial details are undisclosed, sees liquid and powder transfer firm ChargePoint acquire PuroVaso to complement “the existing product range, giving pharmaceutical manufacturers a broader choice of world-class powder and liquid transfer, storage, and handling products that solve customers’ application-specific problems with enhanced productivity,” a spokesperson for the firm told us. According to ChargePoint, the decision to…

August 30, 2022